MDNU Medical Nutrition Usa (MM)

Medical Nutrition USA, Inc. (NASDAQ: MDNU) announced today that an in-depth interview with its Chairman and Chief Executive Officer, Frank A. Newman, appeared recently in The Wall Street Transcript, an independent information resource for the financial and investment community.

Over the course of a comprehensive interview, Mr. Newman provided insight into the company's operations, market opportunity and financial performance. Highlights from Mr. Newman's interview include:

Market outlook -- "The institutional nutritional supplement market is about $4 billion in the U.S. and growing at over 12% a year. That rate of growth is likely to increase as the over-65 year age cohort in the U.S. increases from under 40 million today to 55 million by 2020 and over 70 million by 2030. We are in position to benefit significantly from that demographic shift because of our particular focus on geriatric care in nursing homes, acute-care facilities and dialysis clinics."

Balance sheet -- "We are debt-free, with about $0.70 per share in cash and we generate good cash flow. We don't need to invest much in the way of additional cash to support organic growth. But we are on the lookout for complementary acquisitions that would contribute additional revenue and broaden our product base."

Future milestones -- "[Our success] will come from improved return on sales through improved operating margins as SG&A expenses as a percentage of sales continue to decline. We have made significant investments in growth over the past few years and are now in a position where much of our top line growth will fall to the bottom line."

The complete interview with Mr. Newman is available as a PDF located on Medical Nutrition's website at: http://ir.medicalnutritionusa.com/events.cfm.

About Medical Nutrition USA, Inc.

Medical Nutrition USA develops and distributes products for the nutritionally at risk who are under medical supervision. Its products are used primarily in long-term care facilities, hospitals, dialysis clinics and bariatric clinics. The Company's product lines include Pro-Stat®, Fiber-Stat® and UTI-Stat(TM), as well as private label products. Additional information is available at www.mdnu.com.

This news release contains forward-looking statements that are subject to certain risks and uncertainties. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed. Risks and uncertainties that could cause or contribute to such material difference include, but are not limited to, general economic conditions, changes in customer demand, changes in trends in the nursing home, renal care, health food and bariatric surgery markets, changes in competitive pricing for products, and the impact of our competitors' new product introductions. Our future financial condition and results of operations, as well as any forward-looking statements are subject to change and inherent risk and uncertainties. Other important factors that may cause actual results to differ materially from those expressed in forward-looking statements is contained in the Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year ended January 31, 2009 as filed with the Securities and Exchange Commission on April 24, 2009 and Form 10-Q for the quarter ended June 30, 2009 filed on Sept. 11, 2009.

Contacts: Medical Nutrition USA, Inc. Frank J. Kimmerling Vice President/CFO 800.221.0308 Email Contact Investor Relations Adam Friedman 212.981.2529 x18 Email Contact